|
PSMB2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.6205999999821E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.007260E-04 |
| Normal-vs-Stage2 |
3.293000E-01 |
| Normal-vs-Stage3 |
4.387800E-04 |
| Normal-vs-Stage4 |
4.6374999995713E-07 |
| Stage1-vs-Stage2 |
9.331700E-02 |
| Stage1-vs-Stage3 |
5.359000E-01 |
| Stage1-vs-Stage4 |
4.096200E-03 |
| Stage2-vs-Stage3 |
8.136000E-02 |
| Stage2-vs-Stage4 |
6.151800E-04 |
| Stage3-vs-Stage4 |
2.797700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.21529999996817E-06 |
| Normal-vs-AfricanAmerican |
2.315700E-02 |
| Normal-vs-Asian |
5.641700E-02 |
| Caucasian-vs-AfricanAmerican |
5.869600E-01 |
| Caucasian-vs-Asian |
2.235200E-01 |
| AfricanAmerican-vs-Asian |
1.744850E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.763330E-04 |
| Normal-vs-Female |
2.93459999634038E-08 |
| Male-vs-Female |
2.549700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.260700E-03 |
| Normal-vs-Age(41-60Yrs) |
5.99070000000257E-05 |
| Normal-vs-Age(61-80Yrs) |
1.55809999999867E-05 |
| Normal-vs-Age(81-100Yrs) |
1.645820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.691400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.213600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.429200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.355600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.959400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.457800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.533990E-02 |
| Normal-vs-Grade 2 |
4.05290000000669E-05 |
| Normal-vs-Grade 3 |
1.737220E-03 |
| Normal-vs-Grade 4 |
7.87060000506656E-08 |
| Grade 1-vs-Grade 2 |
7.478400E-01 |
| Grade 1-vs-Grade 3 |
5.464800E-01 |
| Grade 1-vs-Grade 4 |
3.076000E-02 |
| Grade 2-vs-Grade 3 |
6.695600E-01 |
| Grade 2-vs-Grade 4 |
7.153300E-04 |
| Grade 3-vs-Grade 4 |
2.036600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.187600E-04 |
| Normal-vs-ccB subtype |
2.426700E-04 |
| ccA subtype-vs-ccB subtype |
2.508200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.42069999999428E-05 |
| Normal-vs-N1 |
1.782170E-03 |
| N0-vs-N1 |
8.320400E-03 |
|
|
